This is when the real progress often begins
The medication became available by prescription in early January 2026, offering a non-injectable alternative to the weekly Wegovy injection
Retatrutides mechanism must be interpreted alongside randomized trial results, adverse event patterns, discontinuation rates, and regulator review [4], [5], [7], [8]
Sources: EMBRAZE Phase 2 press release Scholar Rock, June 2025 EMBRAZE full publication Nature Medicine, 2026 BELIEVE trial: bimagrumab + semaglutide HCPLive, May 2026 Lilly pauses bimagrumab trial BioPharma Dive, Sept
Key considerations: Store lyophilized (unreconstituted) peptide at -20 degrees Celsius or colder for long-term storage
All three drugs reduced food intake, but the appetite-suppressing effect of tesofensine lasted longer than the other two drugs